Edition:
United States

Divi's Laboratories Ltd (DIVI.NS)

DIVI.NS on National Stock Exchange of India

1,083.05INR
20 Jun 2018
Change (% chg)

-- (--)
Prev Close
Rs1,083.05
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
591,280
52-wk High
Rs1,223.00
52-wk Low
Rs611.00

Latest Key Developments (Source: Significant Developments)

Divi's Laboratories says US FDA's import alert on unit II at Vishakhapatnam removed‍​
Tuesday, 14 Nov 2017 10:18pm EST 

Nov 15 (Reuters) - Divi's Laboratories Ltd ::Says US FDA's import alert 66-40 on co's unit II at Vishakhapatnam has been removed‍​.  Full Article

Divi's Laboratories USFDA completed evaluation of co's corrective actions in response to warning letter
Thursday, 9 Nov 2017 10:36pm EST 

Nov 10 (Reuters) - Divi's Laboratories Ltd :Informed that USFDA completed evaluation of co's corrective actions in response to FDA's warning letter dated April 13.  Full Article

Divi's Labs says U.S.FDA to lift import alert on co's unit-II at Visakhapatnam​
Wednesday, 1 Nov 2017 11:11pm EDT 

Nov 2 (Reuters) - Divi's Laboratories Ltd ::U.S.FDA to lift import alert 66-40 and move to close out warning letter issued to co's unit-II at Visakhapatnam​.  Full Article

India's Divi's Laboratories Sept-qtr profit falls
Tuesday, 31 Oct 2017 09:15am EDT 

Oct 31 (Reuters) - Divi's Laboratories Ltd :Sept quarter net profit 2.07 billion rupees versus profit of 2.24 billion rupees year ago.Sept quarter revenue from operations 8.90 billion rupees versus 10.05 billion rupees year ago.Says revenue during current half of year has been impacted due to‍​ FDA import alert, export shipments delay.  Full Article

Divi's Laboratories gets form 483 with 6 observations at unit-2 on USFDA inspection
Wednesday, 20 Sep 2017 01:10am EDT 

Sept 20 (Reuters) - Divi's Laboratories Ltd ::Says Divi's Laboratories Limited, unit-2 has been inspected by US-FDA from September 11 to September 19, 2017.Inspection was for full CGMP and verification of all corrective actions proposed against previous inspection observations.On completion of inspection, co got form 483 citing 6 observations which are procedural.  Full Article

Divi's Laboratories says U.S. FDA will lift import alert 99-32 imposed on unit-II at Visakhapatnam
Monday, 10 Jul 2017 02:24am EDT 

July 10 (Reuters) - Divi's Laboratories Ltd :Says informed by US-FDA that it will lift import alert 99-32 imposed on company's unit-II at Visakhapatnam.Says has filed a detailed responses and given updates to form-483 and warning letter within stipulated time.Says has taken up appropriate remediation measures to address concerns raised by US-FDA.Says company awaits further action from US-FDA.  Full Article

India's Divi's Labs March-qtr profit falls
Friday, 26 May 2017 08:49am EDT 

May 26 (Reuters) - India's Divi's Laboratories Ltd :March quarter net profit 2.59 billion rupees versus profit3.22 billion rupees year ago.March quarter total revenue from operations 10.88 billion rupees versus 11.21 billion rupees year ago.Recommended dividend of 10 rupees per share.Says got warning letter from FDA for unit -II at vishakapatnam.Says co repsonded to observations in form 483.  Full Article

Divi's Labs says co takes steps to meet FDA's compliance needs after import alert on Visakhapatnam plant
Wednesday, 22 Mar 2017 07:21am EDT 

Divi's Laboratories Ltd : FDA import alert for products manufactured at co's unit-II at Visakhapatnam was issued under 2 clauses 66-40 & 99-32 of FDA regulations . Says company has already initiated necessary measures to address concerns raised by US-FDA .Says co is making all efforts to fully meet compliance requirements.  Full Article

Divi's Labs says USFDA issued import alert on products made at Visakhapatnam unit-II
Monday, 20 Mar 2017 11:27pm EDT 

Divi's Laboratories Ltd :Says import alert 66-40 issued by US-FDA on products manufactured at co's unit-II at Visakhapatnam, Andhra Pradesh.  Full Article

Divi's Labs gets form 483 from USFDA after inspection at Vishakapatnam unit
Wednesday, 7 Dec 2016 06:03am EST 

Divi's Laboratories Ltd : Says co's unit-II at Vishakapatnam had an inspection by USFDA from Nov 29-Dec 6 .Says co has been issued a form 483 with 5 observations.  Full Article